IAVI appoints Margaret McGlynn president and CEO
This article was originally published in Scrip
The International AIDS Vaccine Initiative has appointed Margaret McGlynn president and chief executive officer. Ms McGlynn, who has been a member of IAVI's board of directors since July 2010, replaces Seth Berkley, the organisation's founding president and CEO. Ms McGlynn was previously head of Merck's vaccines and infectious diseases business, and served on the board of the GAVI Alliance.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.